CADUET
BGP PHARMA ULC
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of CADUET in Canada?
Yes. CADUET 10MG 40MG has an active shortage reported to Health Canada (last updated November 8, 2026).
Why is CADUET not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will CADUET be available again?
The manufacturer's estimated resolution date is December 8, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
DIN
02273306
Strength
10MG 40MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
AMLODIPINE ATORVASTATIN
Compare with another product →
Shortage Timeline
Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.
Shortage History
Other Products from BGP PHARMA ULC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.